The pharmacotherapy of Parkinsonism.
D000109:Acetylcholine; D000978:Antiparkinson Agents; D001532:Atropa belladonna / Q000627:therapeutic use; D001921:Brain / Q000378:metabolism; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use; D004298:Dopamine; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D009638:Norepinephrine; D010276:Parasympatholytics / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D010640:Phenothiazines / Q000627:therapeutic use; D008517:Phytotherapy; D010946:Plants, Medicinal; D010947:Plants, Toxic; D012701:Serotonin; D013035:Spasm; D009435:Synaptic Transmission; D014202:Tremor
D000978:Antiparkinson Agents; D006634:Histamine H1 Antagonists; D010276:Parasympatholytics; D010640:Phenothiazines; D012701:Serotonin; D004295:Dihydroxyphenylalanine; D000109:Acetylcholine; D004298:Dopamine; D009638:Norepinephrine